Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001396835-16-000015
Filing Date
2016-02-16
Accepted
2016-02-16 14:53:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 actcamd1.txt SC 13G/A 8568
  Complete submission text file 0001396835-16-000015.txt   10450
Mailing Address 33 LOCKE DRIVE MARLBOROUGH MA 01752
Business Address 33 LOCKE DRIVE MARLBOROUGH MA 01752 508-756-1212
Ocata Therapeutics, Inc. (Subject) CIK: 0001140098 (see all company filings)

EIN.: 870656515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-79462 | Film No.: 161426902
SIC: 2834 Pharmaceutical Preparations

Mailing Address 574 SYLVAN AVENUE SUITE 100 ENGLEWOOD CLIFFS NJ 07632
Business Address 574 SYLVAN AVENUE SUITE 100 ENGLEWOOD CLIFFS NJ 07632 201-871-0866
ALPINE ASSOCIATES MANAGEMENT INC. (Filed by) CIK: 0001396835 (see all company filings)

EIN.: 222548436 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A